12-51912437-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000020.3(ACVRL1):​c.-5-33C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.081 in 1,611,008 control chromosomes in the GnomAD database, including 5,581 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.077 ( 488 hom., cov: 32)
Exomes 𝑓: 0.081 ( 5093 hom. )

Consequence

ACVRL1
NM_000020.3 intron

Scores

2
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.272

Publications

17 publications found
Variant links:
Genes affected
ACVRL1 (HGNC:175): (activin A receptor like type 1) This gene encodes a type I cell-surface receptor for the TGF-beta superfamily of ligands. It shares with other type I receptors a high degree of similarity in serine-threonine kinase subdomains, a glycine- and serine-rich region (called the GS domain) preceding the kinase domain, and a short C-terminal tail. The encoded protein, sometimes termed ALK1, shares similar domain structures with other closely related ALK or activin receptor-like kinase proteins that form a subfamily of receptor serine/threonine kinases. Mutations in this gene are associated with hemorrhagic telangiectasia type 2, also known as Rendu-Osler-Weber syndrome 2. [provided by RefSeq, Jul 2008]
ACVRL1 Gene-Disease associations (from GenCC):
  • telangiectasia, hereditary hemorrhagic, type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp
  • hereditary hemorrhagic telangiectasia
    Inheritance: AR, AD Classification: SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0028590858).
BP6
Variant 12-51912437-C-T is Benign according to our data. Variant chr12-51912437-C-T is described in ClinVar as [Benign]. Clinvar id is 136292.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0873 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ACVRL1NM_000020.3 linkc.-5-33C>T intron_variant Intron 1 of 9 ENST00000388922.9 NP_000011.2 P37023A0A0S2Z310

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ACVRL1ENST00000388922.9 linkc.-5-33C>T intron_variant Intron 1 of 9 1 NM_000020.3 ENSP00000373574.4 P37023

Frequencies

GnomAD3 genomes
AF:
0.0770
AC:
11709
AN:
152122
Hom.:
487
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0629
Gnomad AMI
AF:
0.0385
Gnomad AMR
AF:
0.0803
Gnomad ASJ
AF:
0.0943
Gnomad EAS
AF:
0.0942
Gnomad SAS
AF:
0.0540
Gnomad FIN
AF:
0.0955
Gnomad MID
AF:
0.0823
Gnomad NFE
AF:
0.0817
Gnomad OTH
AF:
0.0803
GnomAD2 exomes
AF:
0.0838
AC:
21002
AN:
250560
AF XY:
0.0823
show subpopulations
Gnomad AFR exome
AF:
0.0609
Gnomad AMR exome
AF:
0.0959
Gnomad ASJ exome
AF:
0.102
Gnomad EAS exome
AF:
0.0788
Gnomad FIN exome
AF:
0.103
Gnomad NFE exome
AF:
0.0862
Gnomad OTH exome
AF:
0.0825
GnomAD4 exome
AF:
0.0815
AC:
118853
AN:
1458768
Hom.:
5093
Cov.:
32
AF XY:
0.0808
AC XY:
58625
AN XY:
725826
show subpopulations
African (AFR)
AF:
0.0627
AC:
2095
AN:
33420
American (AMR)
AF:
0.0919
AC:
4107
AN:
44672
Ashkenazi Jewish (ASJ)
AF:
0.101
AC:
2629
AN:
26102
East Asian (EAS)
AF:
0.118
AC:
4677
AN:
39688
South Asian (SAS)
AF:
0.0595
AC:
5128
AN:
86152
European-Finnish (FIN)
AF:
0.104
AC:
5567
AN:
53338
Middle Eastern (MID)
AF:
0.0546
AC:
315
AN:
5768
European-Non Finnish (NFE)
AF:
0.0808
AC:
89587
AN:
1109314
Other (OTH)
AF:
0.0787
AC:
4748
AN:
60314
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.451
Heterozygous variant carriers
0
5518
11036
16555
22073
27591
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3342
6684
10026
13368
16710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0769
AC:
11710
AN:
152240
Hom.:
488
Cov.:
32
AF XY:
0.0764
AC XY:
5687
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.0628
AC:
2608
AN:
41554
American (AMR)
AF:
0.0802
AC:
1227
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0943
AC:
327
AN:
3468
East Asian (EAS)
AF:
0.0942
AC:
487
AN:
5170
South Asian (SAS)
AF:
0.0543
AC:
262
AN:
4826
European-Finnish (FIN)
AF:
0.0955
AC:
1013
AN:
10602
Middle Eastern (MID)
AF:
0.0782
AC:
23
AN:
294
European-Non Finnish (NFE)
AF:
0.0817
AC:
5558
AN:
68004
Other (OTH)
AF:
0.0804
AC:
170
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
549
1099
1648
2198
2747
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
136
272
408
544
680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0847
Hom.:
782
Bravo
AF:
0.0768
TwinsUK
AF:
0.0809
AC:
300
ALSPAC
AF:
0.0781
AC:
301
ESP6500AA
AF:
0.0608
AC:
268
ESP6500EA
AF:
0.0841
AC:
723
ExAC
AF:
0.0830
AC:
10074
Asia WGS
AF:
0.0830
AC:
290
AN:
3478
EpiCase
AF:
0.0872
EpiControl
AF:
0.0855

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Telangiectasia, hereditary hemorrhagic, type 2 Benign:2
Nov 29, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Oct 22, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.25
CADD
Benign
3.3
DANN
Benign
0.88
DEOGEN2
Benign
0.0056
.;.;T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.049
N
LIST_S2
Benign
0.40
T;T;T
MetaRNN
Benign
0.0029
T;T;T
MetaSVM
Benign
-0.78
T
PhyloP100
0.27
PROVEAN
Benign
-0.43
N;N;N
REVEL
Benign
0.18
Sift
Pathogenic
0.0
D;D;D
Sift4G
Pathogenic
0.0
.;D;T
Polyphen
0.0
.;.;B
Vest4
0.024, 0.094
ClinPred
0.0041
T
GERP RS
-6.7
PromoterAI
-0.063
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2277382; hg19: chr12-52306221; API